{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:43:40Z","timestamp":1771829020621,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":5765,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.jpainsymman.2003.09.006","type":"journal-article","created":{"date-parts":[[2004,3,30]],"date-time":"2004-03-30T05:20:36Z","timestamp":1080624036000},"page":"352-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose"],"prefix":"10.1016","volume":"27","author":[{"given":"Sebastiano","family":"Mercadante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Villari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Ferrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Casuccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3959(90)90004-W","article-title":"Breakthrough pain: definition, prevalence and characteristics","volume":"41","author":"Portenoy","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0304-3959(99)00073-1","article-title":"An international survey of cancer pain characteristics and syndromes","volume":"82","author":"Caraceni","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/cncr.10249","article-title":"Episodic (breakthrough) pain","volume":"94","author":"Mercadante","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0305-7372(98)90005-6","article-title":"Breakthrough pain in cancer patients: pathophysiology and treatment","volume":"24","author":"Mercadante","year":"1998","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3959(92)90155-5","article-title":"Predictive factors in advanced cancer pain treated only by analgesics","volume":"50","author":"Mercadante","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0885-3924(95)00052-Z","article-title":"A prospective multi-center assessment of the Edmonton Staging System for cancer pain","volume":"10","author":"Bruera","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3959(99)00006-8","article-title":"Breakthrough pain: characteristics and impact in patients with cancer pain","volume":"81","author":"Portenoy","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3959(00)00427-9","article-title":"Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulphate immediate release (MSIR)","volume":"91","author":"Coluzzi","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cncr.10636","article-title":"Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion","volume":"95","author":"Mercadante","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB10","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1200\/JCO.1998.16.10.3238","article-title":"Dose-titration multicenter study of transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain","volume":"16","author":"Christie","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jnci\/90.8.611","article-title":"Oral transmucosal fentanyl citrate: a randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients","volume":"90","author":"Farrar","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(98)00179-1","article-title":"Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study","volume":"79","author":"Portenoy","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Morphine and alternative opioids in cancer pain: the EAPC recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB14","series-title":"Management of cancer pain, clinical practice guidelines No.9. AHCPR Publication No.94-0592","author":"Jacox","year":"1994"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/104990910201900512","article-title":"The efficacy and side effects of continuous infusion intravenous morphine (CIVM) for pain and symptoms due to advanced cancer","volume":"19","author":"Glare","year":"2002","journal-title":"Am J Hosp Care"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB16","first-page":"114","article-title":"A model of acute symptom control unit: Pain Relief and Palliative Care Unit of La Maddalena Cancer Center","volume":"11","author":"Mercadante","year":"2003","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(00)00339-0","article-title":"Defining the clinically important difference in pain outcome measures","volume":"88","author":"Farrar","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB18","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1213\/00000539-199909000-00038","article-title":"The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain","volume":"89","author":"Lichtor","year":"1999","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0885-3924(98)00094-3","article-title":"Peak plasma concentrations after oral morphine: a systematic review","volume":"16","author":"Collins","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2003.09.006_BIB20","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/cncr.10518","article-title":"A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids","volume":"94","author":"Enting","year":"2002","journal-title":"Cancer"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392404000041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392404000041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:54:04Z","timestamp":1760129644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392404000041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0885392404000041"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2003.09.006","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2003.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}